Open AccessP616: THE LOSS OF IΚBΕ INHIBITOR ACCELERATES DISEASE DEVELOPMENT IN CHRONIC LYMPHOCYTIC LEUKEMIA
Author(s) -
Lenzi C.,
Bordini J.,
Pseftogkas A.,
Morabito A.,
Tsiolas G.,
Psomopoulos F. E.,
Campanella A.,
Frenquelli M.,
Ghia P.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000845352.28969.97
Subject(s) - bruton's tyrosine kinase , chronic lymphocytic leukemia , ibrutinib , breakpoint cluster region , cancer research , bone marrow , biology , in vivo , b cell , flow cytometry , leukemia , immunology , signal transduction , gene , microbiology and biotechnology , antibody , genetics , tyrosine kinase